Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: London
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Retroscreen Virology Group PLC

+ Add to Watchlist

RVG:LN

240.000 GBp 0.0000.00%

As of 11:35:15 ET on 03/30/2015.

Snapshot for Retroscreen Virology Group PLC (RVG)

Open: 240.000 Day's Range: 240.000 - 240.000 Volume: 0
Previous Close: 240.000 52wk Range: 231.000 - 330.000 1-Yr Rtn: -21.31%

Stock Chart for RVG

No chart data available.
  • RVG:LN 240.000
  • 1D
  • 1M
  • 1Y
240.000
Interactive RVG Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for RVG

Current P/E Ratio (ttm) 75.0000
Estimated P/E(12/2014) -
Relative P/E vs. UKX -
Earnings Per Share (GBP) (ttm) 0.0320
Est. EPS (GBP) (12/2014) -0.2470
Est. PEG Ratio -
Market Cap (M GBP) 163.43
Shares Outstanding (M) 68.10
30 Day Average Volume 16,907
Price/Book (mrq) 3.0087
Price/Sale (ttm) 4.1874
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/08/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for RVG

No data available

Company Profile & Key Executives for RVG

Retroscreen Virology Group PLC conducts bio-medical services. The Company focuses on creating the next generation of antiviral drugs and vaccines for the treatment of a number of viral infections as well as carries out laboratory-based pre-clinical work on behalf of its pharmaceutical company clients. Retroscreen Virology serves clients throughout the world.

Kym Lynn DennyChief Executive OfficerGraham Edward YeatmanFinance Director/Secretary
More Company Profile & Key Executives for RVG

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil